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Figure 1S. Angiopoietin-like 6 has a different expression pattern in livers from patients with metastatic CRC 
compared to livers from healthy donors. A,B. The amounts and localization of angiopoietin-like 6 in livers from 
healthy donors (n=17) (A) and from patients with metastatic CRC (n=79) (B) were evaluated by staining of 5-µm 
paraffin-embedded tissue sections. Exemplary pictures of 16 samples for each tissue panel are shown. Numbers refer to 
the histological archive classification. 
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Figure 2S. Protein quantification in all the described cell lines. 
A,B. For protein quantification, 50 µg of total lysate was loaded on a 10% SDS-polyacrylamide gel, and proteins 
resolved by electrophoresis were blotted onto a PVDF membrane. Membranes were stained with the following primary 
antibodies: mouse monoclonal anti-β4 integrin clone 7, goat polyclonal anti-α6 integrin N-19, mouse monoclonal anti-E-
cadherin clone 36, mouse monoclonal anti-angiopoietin-like 6 clone Kairos-60, goat polyclonal anti-vinculin N-19. 
Vinculin was used as a loading control. (A) U293 cells stably over-expressing E-cadherin, α6Aβ4 integrin, a combination 
of both, or angiopoietin-like 6, (B) CRC cell lines. 
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Figure 3S. Validation of α6 integrin and E-cadherin downmodulation in silenced cell lines. A. Quantification of 
specific mRNA and protein levels in NCI-H630 cells transiently silenced for the expression of ITGA6 and CDH1 
mRNAs. Messenger RNA amounts were evaluated after 24 hours by retrotranscription and Real Time PCR 
amplification of the specific cDNAs. A reduction of 75-85% in both mRNA levels was observed. Protein amounts were 
evaluated after 72 hours by Western Blot. A reduction of 60-70% in both protein levels was observed. Vinculin staining 
was used as a loading control. Results are shown as mean ± standard deviation of 9 independent transfections. B. 
Quantification of protein levels in CRC cell lines stably silenced for the expression of E-cadherin and α6 integrin. HCT-
116m, HT-29, SW-48, and DLD-1 cells were transfected with shRNA plasmid pools targeting ITGA6 or CDH1; non-
targeting control plasmid pool A was used a s a negative control. Following antibiotic selection, 6 clones each were 
analyzed by dotblot to confirm specific protein down-regulations. Red circles indicate clones selected for successive 
experiments, in which a reduction of at least 30-60% in protein levels was achieved. Differences were evaluated for their 
statistical significance by ANOVA followed by Bonferroni’s post-test. 
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UniProt Name Localization Peptide-mimicked 
sequence (aa) Domain 
272-277 Q8NI99 angiopoietin-like 6 soluble 454-459 Fibrinogen 
P24043 laminin alpha 2 soluble 1397-1403 Laminin EGF-like 14 
Q9GZU5 nyctalopin soluble 204-210 LRR6-7 
P10451 osteopontin soluble 164-169  
P98160 perlecan soluble 3017-3022 Ig-like C2-type 15 
Q14392 garpin transmembrane 441-447 LRR-15-16 
Q9UIW2 plexin A1 transmembrane 247-252 Sema 
O14917 protocadherin 17 transmembrane 534-539 Cadherin 5 
O95206 protocadherin 8 transmembrane 561-566 Cadherin 5 
Q9Y5G8 protocadherin γ-A5 transmembrane 163-169 Cadherin 2 
Q9BZZ2 sialoadhesin transmembrane 1391-1397 Ig-like C2-type 14 
Q8WWQ8 stabilin-2 transmembrane 2198-2204 Link 
 
 
 
 
 
 
 
Table 1S. GIYRLRS and GVYSRLS mimic adhesion and matrix proteins. A BLAST analysis was performed to 
investigate possible sequence similarities between the two metastasis-binding peptides (GIYRLRS and GVYSLRS) and 
the human proteome. This analysis revealed that a number of channel proteins and of seven-pass G-protein coupled 
receptors share parts of these sequences in common domains; these proteins are therefore not listed in the table. 
Transmembrane and soluble proteins specifically identified (with score > 25 and e-value < 30) are shown, and their 
SwissProt IDs, name, localization, peptide-mimicked sequence, and corresponding protein domain are listed. 
 
 6 
 
 
UniProt Protein name Score Localization Function 
P12830 E-cadherin 173 cell surface adhesion 
P23229 α6 integrin 98 cell surface adhesion 
P56470 galectin-4 75 cell surface adhesion 
P05026 Na/K-ATPase 94 cell surface channel 
P16444 microsomal dipeptidase 117 cell surface enzyme 
P07900 HSP90 125 cytoplasm chaperone 
P35579 myosin-9 4750 cytoplasm cytoskeleton 
Q7Z406 myosin-14 2408 cytoplasm cytoskeleton 
Q01082 spectrin 1989 cytoplasm cytoskeleton 
O94832 myosin Id 1804 cytoplasm cytoskeleton 
P09327 villin-1 1782 cytoplasm cytoskeleton 
Q00610 clathrin1 1556 cytoplasm cytoskeleton 
O43795 myosin Ib 1252 cytoplasm cytoskeleton 
P07355 annexin A2 994 cytoplasm cytoskeleton 
O00159 myosin Ic 908 cytoplasm cytoskeleton 
P60709 actin 895 cytoplasm cytoskeleton 
Q13813 spectrin 790 cytoplasm cytoskeleton 
Q9NYL9 tropomodulin-3 758 cytoplasm cytoskeleton 
Q12965 myosin Ie 583 cytoplasm cytoskeleton 
P06753 tropomyosin 3 420 cytoplasm cytoskeleton 
P68363 α-tubulin 258 cytoplasm cytoskeleton 
P09525 annexin A4 237 cytoplasm cytoskeleton 
P35580 myosin-10 235 cytoplasm cytoskeleton 
Q9P2M7 cingulin 224 cytoplasm cytoskeleton 
O15143 actin-related protein 2/3 sub1B 193 cytoplasm cytoskeleton 
P35611 α-adducin 98 cytoplasm cytoskeleton 
O15144 actin-related protein 2/3 sub2 96 cytoplasm cytoskeleton 
P68371 β-tubulin 84 cytoplasm cytoskeleton 
Q9UJZ1 stomatin-like protein 2 81 cytoplasm cytoskeleton 
P09874 poly(ADP-ribose) polymerase 106 cytoplasm enzyme 
P16152 NADPH-carbonyl reductase 74 cytoplasm enzyme 
P63092 G-nucleotide-binding protein 98 cytoplasm G protein 
P61247 40S ribosomal protein S3a 224 cytoplasm ribosome 
P45880 voltage-dependent channel 111 mitochondrium channel 
P25705 ATP synthase 200 mitochondrium enzyme 
P19338 nucleolin 236 nucleus chromatin binding 
Q00839 hnRNPU 124 nucleus DNA/RNA binding 
 
 
Table 2S. CGIYRLRSC is a candidate ligand for an adhesion complex on hepatic metastasis cells. NCI-H630 
(target) and HepG2 (control) cell lysates were incubated with GST-CGIYRLRSC. Selectively bound protein were 
separated by gel elecrophoresis and were identified by LC-MS/MS. UniProt IDs, protein names and MASCOT 
identification scores of the identified proteins are listed. General protein localizations/functions are also shown. 
